Clinical Trial Update: Soy Estrogen Alternative Study (SEA) [Phase 2]

View source ↗

Summary

The Soy Estrogen Alternative Study (SEA), a Phase 2 clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI), has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Endometrial Hyperplasia
• Menopause

Drugs mentioned

• Soy Estrogen Alternative (SEA) (soy estrogen alternative)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Endometrial Hyperplasia | Phase 2 | Status: COMPLETED